Oncology Institute Inc (TOI) — Cash Flow Reinvestment Rate
Oncology Institute Inc (TOI) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting $1.06 Million (capex $1.06 Million ) from operating cash flow of $3.23 Million. Check TOI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncology Institute Inc Cash Flow Reinvestment Rate (2018–2020)
Historical reinvestment intensity for Oncology Institute Inc across 3 annual periods. Explore TOI long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Oncology Institute Inc (2018–2020)
Year-by-year capital reinvestment analysis for Oncology Institute Inc. For live market cap and broader valuation context, see TOI market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 19.76x | $10.04 Million | $508.00K | $1.19 Million | ▲ +2865.3% |
| 2019 | 0.67x | $2.41 Million | $3.62 Million | $1.20 Million | ▲ +18.1% |
| 2018 | 0.56x | $3.18 Million | $5.64 Million | $695.96K | — |